Evidence map›Paper›PMID 40398386›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2025

2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-naive and castration-sensitive prostate cancer (Update).

Alan I So, Kim Chi, Brita Danielson, Neil Fleshner, Adam Kinnaird, Tamim Niazi, Frédéric Pouliot, Ricardo A Rendon, Bobby Shayegan, Srikala S Sridhar and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alan I SoDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Kim ChiDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada.
Brita DanielsonDepartment of Oncology, Division of Radiation Oncology, University of Alberta, Edmonton, AB, Canada.
Neil FleshnerDivision of Urology, University of Toronto, Toronto, ON, Canada.
Adam KinnairdDivision of Urology, Department of Surgery, University of Alberta, Edmonton, AB, Canada.
Tamim NiaziDepartment of Oncology, Division of Radiation Oncology, McGill University, Montreal QC, Canada.
Frédéric PouliotDivision of Urology, Department of Surgery, Université Laval, Quebec, QC, Canada.
Ricardo A RendonDepartment of Urology, Dalhousie University, Halifax, NS, Canada.
Bobby ShayeganDepartment of Surgery, McMaster University, Hamilton, ON, Canada.
Srikala S SridharDivision of Hematology and Medical Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
Eric VigneaultDepartment of Radiation Oncology, CHUQ, Université Laval, Quebec City, QC, Canada.
Rodney H BreauDepartment of Surgery, University of Ottawa, Ottawa, ON, Canada.
Fred SaadDepartment of Surgery, Université de Montréal, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40398386
PMCPMC12091038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.